Patti Byron
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 1
-
- Cancer Genomics and Diagnostics 2
Patti Byron
7 papers receiving 352 citations
Hit Papers
Peers
Comparison fields: 5 of 43
- Hematology 263
- Public Health, Environmental and Occupational Health 147
- Oncology 129
- Genetics 33
- Pediatrics, Perinatology and Child Health 43
Countries citing papers authored by Patti Byron
This map shows the geographic impact of Patti Byron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patti Byron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patti Byron more than expected).
Fields of papers citing papers by Patti Byron
This network shows the impact of papers produced by Patti Byron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patti Byron. The network helps show where Patti Byron may publish in the future.
Co-authors
The 23 scholars most cited alongside Patti Byron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531 Hit paper breakdown → | 2014 | 313 |
| 2 | 2013 | 11 | |
| 3 | 2013 | 9 | |
| 4 | 2011 | 5 | |
| 5 | 2010 | 11 | |
| 6 | 2010 | 1 | |
| 7 | 2010 | 9 | |
| 8 | 2000 | 0 |
About Patti Byron
Patti Byron is a scholar working on Hematology, Cancer Research, Emergency Medicine, Public Health, Environmental and Occupational Health and Oncology, having authored 8 papers that have together received 359 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Genomics and Diagnostics (2 papers), Neutropenia and Cancer Infections (2 papers), Hematopoietic Stem Cell Transplantation (1 paper), Cancer-related cognitive impairment studies (1 paper) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Hematology (263 citations), Public Health, Environmental and Occupational Health (147 citations), Oncology (129 citations), Genetics (33 citations) and Pediatrics, Perinatology and Child Health (43 citations). Patti Byron has collaborated with scholars based in United States, Canada and Argentina. Frequent co-authors include Robert B. Gerbing, Amy Heerema‐McKenney, Kathleen Glick, Laura Winter, Samir B. Kahwash, Richard Aplenc, Franklin O. Smith, Alan S. Gamis, Soheil Meshinchi and Todd A. Alonzo. Their work appears in journals such as Blood, Journal of Clinical Oncology and Seminars in Oncology Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.